Cardiovascular Diseases

Glucosamine Supplement Linked to Lower CVD Risk

A UK prospective cohort study suggested that habitual use of glucosamine supplement to relieve osteoarthritis pain might also be related to lower risks of cardiovascular diseases (CVD) events. The study enrolled 466 039 participants from 2006 to 2010. During a median follow-up of 7 years, there were 10 204 incident CVD events, 3060 CVD deaths, 5745 coronary heart disease events, and 3263 stroke events. After adjustment for age, sex, body mass index, race, lifestyle factors, dietary intakes, drug use, and other supplement use, glucosamine use was associated with a significantly lower risk of total CVD events (hazard ratio 0.85), CVD death (0.78), coronary heart disease (0.82), and stroke (0.91). The findings are in line with several previous studies and suggest that glucosamine might have a preventive role in CVD through anti-inflammatory and mimicking a low carbohydrate diet properties. Source: https://www.bmj.com/

hyangiu

Recent Posts

Salt Substitution May Reduce Recurrent Stroke and Death

A prespecified subgroup analysis of a Chinese randomized clinical trial suggested that salt substitution significantly…

2 weeks ago

CBT-Based Programs for IBS

Cognitive Behavioral Therapy (CBT) has been shown to be effective in managing Irritable Bowel Syndrome…

2 weeks ago

Online Programs for Anxiety Disorders

MindShift CBT (Free) – A mobile app based on cognitive-behavioral therapy (CBT) principles, helping users…

2 weeks ago

Supine High BP Increases CVD Risk and Mortality

A US prospective cohort analysis suggested that supine high blood pressure (BP) regardless of seated…

3 weeks ago

Diet-Wide Prospective Study on Diet and Colorectal Cancer

A UK prospective study on diet and colorectal cancer found a marked positive association for…

1 month ago

Mediterranean Diet May Slow Atherosclerosis Progression and Prevent CHD

A Spanish secondary prevention study suggested that Mediterranean diet might reduce neutrophil levels and slow…

2 months ago

This website uses cookies.